Point prevalence survey of antibiotic use in hospitals in Latin American countries

Descripción del Articulo

Background: Point prevalence surveys (PPSs) on antibiotic use are useful for understanding different aspects related to prescription patterns in hospitals. Methods: An adaptation of the WHO methodology for a PPS on antibiotic use was applied. Hospital wards were divided into medical (MED), surgical...

Descripción completa

Detalles Bibliográficos
Autores: Levy Hara, G, Rojas-Cortes, R, Molina León, HF, Dreser Mansilla, A, Alfonso Orta, I, Rizo-Amezquita, JN, Santos Herrera, RG, Mendoza De Ayala, S, Arce Villalobos, M, Mantilla Ponte, H, Davila E, Aguilar, G, Porrás, A, Ramón-Pardo, P, Castro, JL, Guzmán, D, Rioseco, ML, Labarca, J, Madriz, JPD, Cubero, JM, Calderón AR, Alfaro, M, Soto, LA, Aayon, A, Oreamuno, TJ, Jimenez, Z, Sequeira, A, Hernández, JM, Lavaut, JLC, Meriño, DC, Ruisanchez, EF, Sánchez, DP, Garcell, HG, Socias, JJP, Diáz, EP, Lunar, NAC, Lancis, IF, Ramírez, JAÁ, Leyte, ML, Rosabal, AM, Estrada, EA, Cano, M, Mendez, L, Eiriz, AC, Menendez, LP, Fernández, GF, Ayala, RR, Monroy, S, Menjívar, R, Martínez, CEA, Cabrera, D, Delgado, SMM, Guzmán, GAM, Mejiá, R, Rodríguez, C, Alvarenga, S, Alvarado, M, De Zelaya, RDCA, Arevalo, G, Parada, G, Cuellar, L, Ruiz, AH, Pinedo, YA, Vergaray, ES, Gil, LEV, Ibazeta, BGI, Ricra, EDG, Segura, RE, Apac, CG, Inga, JC, Diáz, RH, Vigo, MV, Cuba, CM, Vilcapoma, P, Angles-Yanqui, E, Terrones, DRM, Robles, RT, Resurrección, C, Gonzalez, AC, Antezana, M, Zegarra, ST, Villegas-Chiroque, M, Diáz-Sipión, R, Benítez-Peche, J, Rosas, JLA, Ruiz, JLG, Fernández, AMH, Vargas, JAF, Araujo, J, Garciá, FJA, Rivera, ZC, Colín, VM, Ríos, KB, Blanquel, JIH, De La Garza, EA, Gutierrez, HH, León, K, Lara, HEP, Arias, CB, Garay, EA, Sanabria, GE
Formato: artículo
Fecha de Publicación:2022
Institución:Instituto Nacional de Enfermedades Neoplásicas
Repositorio:INEN-Institucional
Lenguaje:inglés
OAI Identifier:oai:repositorio.inen.sld.pe:20.500.14703/327
Enlace del recurso:https: //doi.org/10.1093/jac/dkab459
https://hdl.handle.net/20.500.14703/327
Nivel de acceso:acceso abierto
Materia:Anti-Bacterial Agents
Cross Infection
Hospitals
Humans
Latin America
Prevalence
https://purl.org/pe-repo/ocde/ford#3.02.21
id INEN_faa930a256705229a98c2827a540df2b
oai_identifier_str oai:repositorio.inen.sld.pe:20.500.14703/327
network_acronym_str INEN
network_name_str INEN-Institucional
repository_id_str .
dc.title.none.fl_str_mv Point prevalence survey of antibiotic use in hospitals in Latin American countries
title Point prevalence survey of antibiotic use in hospitals in Latin American countries
spellingShingle Point prevalence survey of antibiotic use in hospitals in Latin American countries
Levy Hara, G
Anti-Bacterial Agents
Cross Infection
Hospitals
Humans
Latin America
Prevalence
https://purl.org/pe-repo/ocde/ford#3.02.21
title_short Point prevalence survey of antibiotic use in hospitals in Latin American countries
title_full Point prevalence survey of antibiotic use in hospitals in Latin American countries
title_fullStr Point prevalence survey of antibiotic use in hospitals in Latin American countries
title_full_unstemmed Point prevalence survey of antibiotic use in hospitals in Latin American countries
title_sort Point prevalence survey of antibiotic use in hospitals in Latin American countries
dc.creator.fl_str_mv Menchaca, LM
Vire, NL
Acuña, D
Caballero, EG
author Levy Hara, G
author_facet Levy Hara, G
Rojas-Cortes, R
Molina León, HF
Dreser Mansilla, A
Alfonso Orta, I
Rizo-Amezquita, JN
Santos Herrera, RG
Mendoza De Ayala, S
Arce Villalobos, M
Mantilla Ponte, H
Davila E
Aguilar, G
Porrás, A
Ramón-Pardo, P
Castro, JL
Guzmán, D
Rioseco, ML
Labarca, J
Madriz, JPD
Cubero, JM
Calderón AR
Alfaro, M
Soto, LA
Aayon, A
Oreamuno, TJ
Jimenez, Z
Sequeira, A
Hernández, JM
Lavaut, JLC
Meriño, DC
Ruisanchez, EF
Sánchez, DP
Garcell, HG
Socias, JJP
Diáz, EP
Lunar, NAC
Lancis, IF
Ramírez, JAÁ
Leyte, ML
Rosabal, AM
Estrada, EA
Cano, M
Mendez, L
Eiriz, AC
Menendez, LP
Fernández, GF
Ayala, RR
Monroy, S
Menjívar, R
Martínez, CEA
Cabrera, D
Delgado, SMM
Guzmán, GAM
Mejiá, R
Rodríguez, C
Alvarenga, S
Alvarado, M
De Zelaya, RDCA
Arevalo, G
Parada, G
Cuellar, L
Ruiz, AH
Pinedo, YA
Vergaray, ES
Gil, LEV
Ibazeta, BGI
Ricra, EDG
Segura, RE
Apac, CG
Inga, JC
Diáz, RH
Vigo, MV
Cuba, CM
Vilcapoma, P
Angles-Yanqui, E
Terrones, DRM
Robles, RT
Resurrección, C
Gonzalez, AC
Antezana, M
Zegarra, ST
Villegas-Chiroque, M
Diáz-Sipión, R
Benítez-Peche, J
Rosas, JLA
Ruiz, JLG
Fernández, AMH
Vargas, JAF
Araujo, J
Garciá, FJA
Rivera, ZC
Colín, VM
Ríos, KB
Blanquel, JIH
De La Garza, EA
Gutierrez, HH
León, K
Lara, HEP
Arias, CB
Garay, EA
Sanabria, GE
author_role author
author2 Rojas-Cortes, R
Molina León, HF
Dreser Mansilla, A
Alfonso Orta, I
Rizo-Amezquita, JN
Santos Herrera, RG
Mendoza De Ayala, S
Arce Villalobos, M
Mantilla Ponte, H
Davila E
Aguilar, G
Porrás, A
Ramón-Pardo, P
Castro, JL
Guzmán, D
Rioseco, ML
Labarca, J
Madriz, JPD
Cubero, JM
Calderón AR
Alfaro, M
Soto, LA
Aayon, A
Oreamuno, TJ
Jimenez, Z
Sequeira, A
Hernández, JM
Lavaut, JLC
Meriño, DC
Ruisanchez, EF
Sánchez, DP
Garcell, HG
Socias, JJP
Diáz, EP
Lunar, NAC
Lancis, IF
Ramírez, JAÁ
Leyte, ML
Rosabal, AM
Estrada, EA
Cano, M
Mendez, L
Eiriz, AC
Menendez, LP
Fernández, GF
Ayala, RR
Monroy, S
Menjívar, R
Martínez, CEA
Cabrera, D
Delgado, SMM
Guzmán, GAM
Mejiá, R
Rodríguez, C
Alvarenga, S
Alvarado, M
De Zelaya, RDCA
Arevalo, G
Parada, G
Cuellar, L
Ruiz, AH
Pinedo, YA
Vergaray, ES
Gil, LEV
Ibazeta, BGI
Ricra, EDG
Segura, RE
Apac, CG
Inga, JC
Diáz, RH
Vigo, MV
Cuba, CM
Vilcapoma, P
Angles-Yanqui, E
Terrones, DRM
Robles, RT
Resurrección, C
Gonzalez, AC
Antezana, M
Zegarra, ST
Villegas-Chiroque, M
Diáz-Sipión, R
Benítez-Peche, J
Rosas, JLA
Ruiz, JLG
Fernández, AMH
Vargas, JAF
Araujo, J
Garciá, FJA
Rivera, ZC
Colín, VM
Ríos, KB
Blanquel, JIH
De La Garza, EA
Gutierrez, HH
León, K
Lara, HEP
Arias, CB
Garay, EA
Sanabria, GE
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.none.fl_str_mv Menchaca, LM
Vire, NL
Acuña, D
Caballero, EG
dc.contributor.author.fl_str_mv Levy Hara, G
Rojas-Cortes, R
Molina León, HF
Dreser Mansilla, A
Alfonso Orta, I
Rizo-Amezquita, JN
Santos Herrera, RG
Mendoza De Ayala, S
Arce Villalobos, M
Mantilla Ponte, H
Davila E
Aguilar, G
Porrás, A
Ramón-Pardo, P
Castro, JL
Guzmán, D
Rioseco, ML
Labarca, J
Madriz, JPD
Cubero, JM
Calderón AR
Alfaro, M
Soto, LA
Aayon, A
Oreamuno, TJ
Jimenez, Z
Sequeira, A
Hernández, JM
Lavaut, JLC
Meriño, DC
Ruisanchez, EF
Sánchez, DP
Garcell, HG
Socias, JJP
Diáz, EP
Lunar, NAC
Lancis, IF
Ramírez, JAÁ
Leyte, ML
Rosabal, AM
Estrada, EA
Cano, M
Mendez, L
Eiriz, AC
Menendez, LP
Fernández, GF
Ayala, RR
Monroy, S
Menjívar, R
Martínez, CEA
Cabrera, D
Delgado, SMM
Guzmán, GAM
Mejiá, R
Rodríguez, C
Alvarenga, S
Alvarado, M
De Zelaya, RDCA
Arevalo, G
Parada, G
Cuellar, L
Ruiz, AH
Pinedo, YA
Vergaray, ES
Gil, LEV
Ibazeta, BGI
Ricra, EDG
Segura, RE
Apac, CG
Inga, JC
Diáz, RH
Vigo, MV
Cuba, CM
Vilcapoma, P
Angles-Yanqui, E
Terrones, DRM
Robles, RT
Resurrección, C
Gonzalez, AC
Antezana, M
Zegarra, ST
Villegas-Chiroque, M
Diáz-Sipión, R
Benítez-Peche, J
Rosas, JLA
Ruiz, JLG
Fernández, AMH
Vargas, JAF
Araujo, J
Garciá, FJA
Rivera, ZC
Colín, VM
Ríos, KB
Blanquel, JIH
De La Garza, EA
Gutierrez, HH
León, K
Lara, HEP
Arias, CB
Garay, EA
Sanabria, GE
dc.subject.none.fl_str_mv Anti-Bacterial Agents
Cross Infection
Hospitals
Humans
Latin America
Prevalence
topic Anti-Bacterial Agents
Cross Infection
Hospitals
Humans
Latin America
Prevalence
https://purl.org/pe-repo/ocde/ford#3.02.21
dc.subject.ocde.none.fl_str_mv https://purl.org/pe-repo/ocde/ford#3.02.21
description Background: Point prevalence surveys (PPSs) on antibiotic use are useful for understanding different aspects related to prescription patterns in hospitals. Methods: An adaptation of the WHO methodology for a PPS on antibiotic use was applied. Hospital wards were divided into medical (MED), surgical (SUR), ICUs, gynaecology and obstetrics (GO), high-risk (HR) and mixed wards (MIX). A web application (RedCapVC ) through a mobile device was used for data collection. Results: Between December 2018 and August 2019, 5444 patients in 33 hospitals in five countries were included (10 hospitals in Cuba, 7 in Paraguay, 6 in El Salvador, 5 in Mexico and 5 in Peru). Of these patients, 54.6%received at least one antibiotic, with variations between and within hospitals and countries. Antibiotics were more frequently used in ICUs (67.2%), SUR (64.5%) and MED wards (54.2%), with 51.2% of antibiotics prescribed for community-acquired infections (CAIs), 22.9% for healthcare-associated infections (HAIs), 11.1% for surgical prophylaxis and 6.1% for unknown reasons. Adherence to guidelines was observed in 68.6% of cases (72.8% for CAIs, 72.4% for HAIs and 44.3% for prophylaxis). Third-generation cephalosporins were the class of antibiotics most frequently used (26.8%), followed by carbapenems (10.3%) and fluoroquinolones (8%). Targeted treatments were achieved in 17.3%of cases. Conclusions: Antibiotic use was generally higher than that published in other studies. There is an urgent need to promote and strengthen the antimicrobial stewardship programmes in Latin America.
publishDate 2022
dc.date.accessioned.none.fl_str_mv 2025-01-02T14:42:40Z
dc.date.available.none.fl_str_mv 2025-01-02T14:42:40Z
dc.date.issued.fl_str_mv 2022
dc.type.none.fl_str_mv info:eu-repo/semantics/article
dc.type.version.none.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.doi.none.fl_str_mv https: //doi.org/10.1093/jac/dkab459
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/20.500.14703/327
dc.identifier.journal.none.fl_str_mv Journal of Antimicrobial Chemotherapy
url https: //doi.org/10.1093/jac/dkab459
https://hdl.handle.net/20.500.14703/327
identifier_str_mv Journal of Antimicrobial Chemotherapy
dc.language.iso.none.fl_str_mv eng
language eng
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.uri.none.fl_str_mv https://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0/
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Oxford University Press
dc.publisher.country.none.fl_str_mv UK
publisher.none.fl_str_mv Oxford University Press
dc.source.none.fl_str_mv reponame:INEN-Institucional
instname:Instituto Nacional de Enfermedades Neoplásicas
instacron:INEN
instname_str Instituto Nacional de Enfermedades Neoplásicas
instacron_str INEN
institution INEN
reponame_str INEN-Institucional
collection INEN-Institucional
bitstream.url.fl_str_mv https://repositorio.inen.sld.pe/backend/api/core/bitstreams/36efbd65-1171-4dd2-923a-8536e28f26cc/download
https://repositorio.inen.sld.pe/backend/api/core/bitstreams/1973863d-abde-451b-ba6e-1245facef834/download
https://repositorio.inen.sld.pe/backend/api/core/bitstreams/f676fdb1-5442-4229-bf6a-d03099b5de8b/download
bitstream.checksum.fl_str_mv d905d5216c203ebbd8e3062ce0c78cff
8a122bae001a915cece52e898b5e82f4
9455a9e498c3c22da21447408d68f122
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositorio del Instituto Nacional de Enfermedades Neoplásicas
repository.mail.fl_str_mv repositorio@inen.sld.pe
_version_ 1868438553580535808
spelling PublicationMenchaca, LMVire, NLAcuña, DCaballero, EGLevy Hara, GRojas-Cortes, RMolina León, HFDreser Mansilla, AAlfonso Orta, IRizo-Amezquita, JNSantos Herrera, RGMendoza De Ayala, SArce Villalobos, MMantilla Ponte, HDavila EAguilar, GPorrás, ARamón-Pardo, PCastro, JLGuzmán, DRioseco, MLLabarca, JMadriz, JPDCubero, JMCalderón ARAlfaro, MSoto, LAAayon, AOreamuno, TJJimenez, ZSequeira, AHernández, JMLavaut, JLCMeriño, DCRuisanchez, EFSánchez, DPGarcell, HGSocias, JJPDiáz, EPLunar, NACLancis, IFRamírez, JAÁLeyte, MLRosabal, AMEstrada, EACano, MMendez, LEiriz, ACMenendez, LPFernández, GFAyala, RRMonroy, SMenjívar, RMartínez, CEACabrera, DDelgado, SMMGuzmán, GAMMejiá, RRodríguez, CAlvarenga, SAlvarado, MDe Zelaya, RDCAArevalo, GParada, GCuellar, LRuiz, AHPinedo, YAVergaray, ESGil, LEVIbazeta, BGIRicra, EDGSegura, REApac, CGInga, JCDiáz, RHVigo, MVCuba, CMVilcapoma, PAngles-Yanqui, ETerrones, DRMRobles, RTResurrección, CGonzalez, ACAntezana, MZegarra, STVillegas-Chiroque, MDiáz-Sipión, RBenítez-Peche, JRosas, JLARuiz, JLGFernández, AMHVargas, JAFAraujo, JGarciá, FJARivera, ZCColín, VMRíos, KBBlanquel, JIHDe La Garza, EAGutierrez, HHLeón, KLara, HEPArias, CBGaray, EASanabria, GE2025-01-02T14:42:40Z2025-01-02T14:42:40Z2022https: //doi.org/10.1093/jac/dkab459https://hdl.handle.net/20.500.14703/327Journal of Antimicrobial ChemotherapyBackground: Point prevalence surveys (PPSs) on antibiotic use are useful for understanding different aspects related to prescription patterns in hospitals. Methods: An adaptation of the WHO methodology for a PPS on antibiotic use was applied. Hospital wards were divided into medical (MED), surgical (SUR), ICUs, gynaecology and obstetrics (GO), high-risk (HR) and mixed wards (MIX). A web application (RedCapVC ) through a mobile device was used for data collection. Results: Between December 2018 and August 2019, 5444 patients in 33 hospitals in five countries were included (10 hospitals in Cuba, 7 in Paraguay, 6 in El Salvador, 5 in Mexico and 5 in Peru). Of these patients, 54.6%received at least one antibiotic, with variations between and within hospitals and countries. Antibiotics were more frequently used in ICUs (67.2%), SUR (64.5%) and MED wards (54.2%), with 51.2% of antibiotics prescribed for community-acquired infections (CAIs), 22.9% for healthcare-associated infections (HAIs), 11.1% for surgical prophylaxis and 6.1% for unknown reasons. Adherence to guidelines was observed in 68.6% of cases (72.8% for CAIs, 72.4% for HAIs and 44.3% for prophylaxis). Third-generation cephalosporins were the class of antibiotics most frequently used (26.8%), followed by carbapenems (10.3%) and fluoroquinolones (8%). Targeted treatments were achieved in 17.3%of cases. Conclusions: Antibiotic use was generally higher than that published in other studies. There is an urgent need to promote and strengthen the antimicrobial stewardship programmes in Latin America.application/pdfengOxford University PressUKinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/4.0/Anti-Bacterial AgentsCross InfectionHospitalsHumansLatin AmericaPrevalencehttps://purl.org/pe-repo/ocde/ford#3.02.21Point prevalence survey of antibiotic use in hospitals in Latin American countriesinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionreponame:INEN-Institucionalinstname:Instituto Nacional de Enfermedades Neoplásicasinstacron:INENORIGINALdkab459.pdfapplication/pdf286963https://repositorio.inen.sld.pe/backend/api/core/bitstreams/36efbd65-1171-4dd2-923a-8536e28f26cc/downloadd905d5216c203ebbd8e3062ce0c78cffMD51trueAnonymousREADTEXTdkab459.pdf.txtWritten by FormatFilter org.dspace.app.mediafilter.TikaTextExtractionFilter on 2025-08-22T08:02:26Z (GMT).Extracted texttext/plain49000https://repositorio.inen.sld.pe/backend/api/core/bitstreams/1973863d-abde-451b-ba6e-1245facef834/download8a122bae001a915cece52e898b5e82f4MD52falseAnonymousREADTHUMBNAILdkab459.pdf.jpgWritten by FormatFilter org.dspace.app.mediafilter.PDFBoxThumbnail on 2025-08-22T08:02:26Z (GMT).Generated Thumbnailimage/jpeg48183https://repositorio.inen.sld.pe/backend/api/core/bitstreams/f676fdb1-5442-4229-bf6a-d03099b5de8b/download9455a9e498c3c22da21447408d68f122MD53falseAnonymousREAD20.500.14703/327oai:repositorio.inen.sld.pe:20.500.14703/3272026-02-15T18:14:46.766Zhttps://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessopen.accesshttps://repositorio.inen.sld.peRepositorio del Instituto Nacional de Enfermedades Neoplásicasrepositorio@inen.sld.pe
score 12.821158
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).